CORRECTION
Published on 29 May 2025
Corrigendum: Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells
doi 10.3389/fimmu.2025.1625107
- 859 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Modulating Plasmacytoid Dendritic Cells: Balancing Cancer Immunity and Tumor Progression
Modulating Plasmacytoid Dendritic Cells: Balancing Cancer Immunity and Tumor Progression
2,347
Total downloads
9,604
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 27 Mar 2025
Characterization of TLR9 responsiveness in cell subsets derived from in vitro pDC differentiation of hematopoietic stem and progenitor cells
doi 10.3389/fimmu.2025.1550397
- 2,911 views
ORIGINAL RESEARCH
Published on 07 Nov 2024
Human CD34+-derived plasmacytoid dendritic cells as surrogates for primary pDCs and potential cancer immunotherapy
doi 10.3389/fimmu.2024.1433119
- 3,086 views
- 1 citation
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: